MicroRNA-copy number variations in coronary artery disease patients with or without type 2 diabetes mellitus

References

• Afjeh, S.S.A. and Ghaderian, S.M.H., 2013. The role of microRNAs in cardiovascular disease. International journal of molecular and cellular medicine, 2, 50–57.
   PubMedGoogle Scholar
• Akhbari, M., et al., 2018. Expression level of circulating miR-93 in serum of patients with diabetic nephropathy. The Turkish journal of endocrinology and metabolism, 22(2), 78.
   Google Scholar
• Bastami, M., et al., 2016. MiRNA-related polymorphisms in miR-146a and TCF21 are associated with increased susceptibility to coronary artery disease in an Iranian population. Genetic testing and molecular biomarkers, 20(5), 241–248.
   PubMed Web of Science ®Google Scholar
• Beckman, J.A., Creager, M.A., and Libby, P., 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287(19), 2570–2581.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-H., et al., 2013. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes, 62(7), 2278–2286.
   PubMed Web of Science ®Google Scholar
• Coe, B.P., et al., 2014. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nature genetics, 46(10), 1063–1071.
   PubMed Web of Science ®Google Scholar
• Conrad, D.F., et al., 2010. Origins and functional impact of copy number variation in the human genome. Nature, 464(7289), 704–712.
   PubMed Web of Science ®Google Scholar
• Consortium, CaD., et al., 2013. Large-scale association analysis identifies new risk loci for coronary artery disease. Nature genetics, 45, 25–33.
   PubMed Web of Science ®Google Scholar
• Cooper-Dehoff, R.M., et al., 2010. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA, 304(1), 61–68.
   PubMed Web of Science ®Google Scholar
• Cooper, G.M., et al., 2011. A copy number variation morbidity map of developmental delay. Nature genetics, 43(9), 838–846.
   PubMed Web of Science ®Google Scholar
• Costelloe, S.J., et al., 2012. Gene-targeted analysis of copy number variants identifies 3 novel associations with coronary heart disease traits. Circulation: cardiovascular genetics, 5(5), 555–560.
   PubMedGoogle Scholar
• D'haene, B., Vandesompele, J., and Hellemans, J., 2010. Accurate and objective copy number profiling using real-time quantitative PCR. Methods (San Diego, Calif.), 50(4), 262–270.
   PubMed Web of Science ®Google Scholar
• Dogan, H., Can, H., and Otu, H.H., 2014. Whole genome sequence of a Turkish individual. PLoS One, 9(1), e85233.
   PubMed Web of Science ®Google Scholar
• Duan, S., et al., 2009. Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNA biology, 6(4), 412–425.
   PubMed Web of Science ®Google Scholar
• Elmen, J., et al., 2008. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic acids research, 36, 1153–1162.
   PubMed Web of Science ®Google Scholar
• Fang, L., et al., 2011. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene, 30(7), 806–821.
   PubMed Web of Science ®Google Scholar
• Gao, W., et al., 2012. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids in health and disease, 11(1), 55.
   PubMedGoogle Scholar
• Hatmi, Z.N., et al., 2007. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular disorders, 7(1), 32.
   PubMedGoogle Scholar
• Hellemans, J., et al., 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biology, 8(2), R19.
   PubMed Web of Science ®Google Scholar
• Hoebeeck, J., et al., 2005. Rapid detection of VHL exon deletions using real-time quantitative PCR. Laboratory investigation, 85(1), 24.
   PubMed Web of Science ®Google Scholar
• Hsu, P.W., et al., 2006. miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic acids research, 34(90001), D135–D139.
   PubMedGoogle Scholar
• Jiang, Y., et al., 2015. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Scientific reports, 4(1), 5026.
   Google Scholar
• John, F., et al., 2016. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI. International journal of cardiology, 224, 310–316.
   PubMed Web of Science ®Google Scholar
• Kannel, W.B. and Mcgee, D.L., 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA, 241(19), 2035–2038.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2007. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proceedings of the national academy of sciences of the United States of America, 104(9), 3432–3437.
   PubMed Web of Science ®Google Scholar
• Kidd, J.M., et al., 2008. Mapping and sequencing of structural variation from eight human genomes. Nature, 453(7191), 56–64.
   PubMed Web of Science ®Google Scholar
• Lin, C.H., et al., 2008. A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan. BMC genetics, 9(1), 92.
   PubMedGoogle Scholar
• Locke, D.P., et al., 2006. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. The American journal of human genetics, 79(2), 275–290.
   PubMed Web of Science ®Google Scholar
• Long, J., et al., 2010. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. Journal of biological chemistry, 285(30), 23457–23465.
   PubMed Web of Science ®Google Scholar
• Low Wang, C.C., et al., 2016. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus – mechanisms, management, and clinical considerations. Circulation, 133(24), 2459–2502.
   PubMed Web of Science ®Google Scholar
• Madrigal-Matute, J., et al., 2013. MicroRNAs and atherosclerosis. Current atherosclerosis reports, 15(5), 322.
   PubMed Web of Science ®Google Scholar
• Marcinkowska, M., et al., 2011. Copy number variation of microRNA genes in the human genome. BMC genomics, 12, 183.
   PubMed Web of Science ®Google Scholar
• Morita, H. and Nagai, R., 2010. Retinopathy progression in type 2 diabetes. The New England journal of medicine, 363, 2171–2174.
   PubMedGoogle Scholar
• Mu, J., et al., 2013. Functional implications of microRNA-215 in TGF-beta1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS one, 8(3), e58622.
   PubMed Web of Science ®Google Scholar
• Párrizas, M., et al., 2015. Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. The journal of clinical endocrinology & metabolism, 100, E407–E415.
   PubMed Web of Science ®Google Scholar
• Parsa, A.F.Z., Ziai, H., and Fallahi, B., 2010. The relationship between cardiovascular risk factors and the site and extent of coronary artery stenosis during angiography. Tehran university medical journal, 68, 182–187.
   Google Scholar
• Qi, P. and Du, X., 2013. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern pathology : an official journal of the United States and Canadian academy of pathology, Inc, 26(2), 155–165.
   PubMed Web of Science ®Google Scholar
• Rezazadeh, M., et al., 2015. A study on association of polymorphisms in Calpain10 and TCF7L2 genes with type 2 diabetes mellitus. Genetika, 47(1), 161–170.
   Google Scholar
• Rotllan, N. and Fernández-Hernando, C., 2012. MicroRNA regulation of cholesterol metabolism. Cholesterol, 2012, 1.
   Google Scholar
• Sayols-Baixeras, S., et al., 2014. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. The application of clincial genetics, 7, 15–32.
   Google Scholar
• Shaikh, T.H., et al., 2009. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome research, 19(9), 1682–1690.
   PubMed Web of Science ®Google Scholar
• Sousa, A.G., et al., 2011. Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis. The review of diabetic studies, 8(2), 230.
   PubMedGoogle Scholar
• Willeit, P., et al., 2017. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes. Diabetes, 66(2), 347–357.
   PubMed Web of Science ®Google Scholar
• Williams, M.D. and Mitchell, G.M., 2012. MicroRNAs in insulin resistance and obesity. Experimental diabetes research, 2012, 484696.
   PubMedGoogle Scholar
• Wong, K.K., et al., 2007. A comprehensive analysis of common copy-number variations in the human genome. The American journal of human genetics, 80(1), 91–104.
   PubMed Web of Science ®Google Scholar
• Wu, Z., et al., 2014. Copy number variation of the Lipoprotein (a)(LPA) gene is associated with coronary artery disease in a southern Han Chinese population. International journal of clinical and experimental medicine, 7, 3669–3677.
   PubMed Web of Science ®Google Scholar
• Xiong, X.D., et al., 2014. A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutation research/fundamental and molecular mechanisms of mutagenesis, 761, 15–20.
   PubMed Web of Science ®Google Scholar
• Yan, Y.-X., et al., 2018. Association analysis of copy number variations in type 2 diabetes-related susceptible genes in a Chinese population. Acta diabetologica, 55(9), 909–916.
   PubMed Web of Science ®Google Scholar